Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer

Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Epideral growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the most important treatments currently for advanced NSCLC patients harboring activating EGFR gene mutations, and achieve significant clinical efficac...

Full description

Bibliographic Details
Main Authors: Yu ZHANG, Yan XU, Mengzhao WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Plasma
EGFR
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.11.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2016.11.08

Similar Items